| Title |
Primary Prevention of Major Cardiovascular and Cerebrovascular Events with Statins in Diabetic Patients
|
|---|---|
| Published in |
Drugs, December 2012
|
| DOI | 10.2165/11638240-000000000-00000 |
| Pubmed ID | |
| Authors |
Folgerdiena M. de Vries, Petra Denig, Koen B. Pouwels, Maarten J. Postma, Eelko Hak |
| Abstract |
Patients with diabetes mellitus are at increased risk of developing cardiovascular disease. Controlling lipid levels has a preventive effect on the occurrence of major cardiovascular and cerebrovascular events. Individual trials have shown varying data on the efficacy of treatment with lipid-lowering statin therapy in the primary prevention of such events in diabetes. |
X Demographics
The data shown below were collected from the profiles of 21 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 9 | 43% |
| United Kingdom | 1 | 5% |
| Unknown | 11 | 52% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 17 | 81% |
| Practitioners (doctors, other healthcare professionals) | 4 | 19% |
Mendeley readers
The data shown below were compiled from readership statistics for 105 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 2 | 2% |
| Netherlands | 2 | 2% |
| United States | 1 | <1% |
| Unknown | 100 | 95% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 22 | 21% |
| Student > Master | 20 | 19% |
| Student > Bachelor | 10 | 10% |
| Student > Ph. D. Student | 8 | 8% |
| Student > Postgraduate | 8 | 8% |
| Other | 21 | 20% |
| Unknown | 16 | 15% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 47 | 45% |
| Pharmacology, Toxicology and Pharmaceutical Science | 14 | 13% |
| Nursing and Health Professions | 6 | 6% |
| Biochemistry, Genetics and Molecular Biology | 4 | 4% |
| Psychology | 3 | 3% |
| Other | 11 | 10% |
| Unknown | 20 | 19% |
Attention Score in Context
This research output has an Altmetric Attention Score of 26. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 August 2023.
All research outputs
#1,462,974
of 25,373,627 outputs
Outputs from Drugs
#134
of 3,464 outputs
Outputs of similar age
#12,583
of 288,856 outputs
Outputs of similar age from Drugs
#6
of 398 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,464 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.9. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 288,856 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 398 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.